SCHEMBL31736992

SCHEMBL31736992

Cc1cnc(NC2CCNCC2)nc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 3/20 0.64
▸ MAPK8 P45983 2/20 0.46
▸ CYP1A2 P05177 2/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ TYRO3 Q06418 3/20 0.43
▸ AXL P30530 2/20 0.43
▸ MERTK Q12866 2/20 0.43
▸ IKBKB O14920 1/20 0.42
▸ CDK1 P06493 2/20 0.42
▸ CDK4 P11802 2/20 0.42
▸ CCND1 P24385 2/20 0.42
▸ CDK2 P24941 2/20 0.42
▸ CCNB1 P14635 1/20 0.42
▸ CCNA2 P20248 1/20 0.42
▸ CCNA1 P78396 1/20 0.42
▸ HRH3 Q9Y5N1 1/20 0.41
▸ SELP P16109 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2369987 0.86 MAPK1 (0.75) MAPK1MAPK8HDAC1KDM4EGAA
Trifluoroacetic Acid SCHEMBL31619956 0.85 HRH4 (0.52) MAPK1MAPK8CYP1A2TYRO3AXL
SCHEMBL10293575 0.82 MAPK1 (0.70) MAPK1CDK1CDK4CCND1CDK2
SCHEMBL14397338 0.81 HDAC1 (0.45) MAPK1MAPK8CYP1A2CYP3A4MEN1
SCHEMBL31619957 0.81 MAPK1 (0.64) MAPK1MAPK8CYP1A2CYP3A4MEN1
SCHEMBL4701457 0.81 IGF1R (0.46) MAPK1MAPK8CYP1A2CYP3A4MEN1
SCHEMBL31736623 0.81 IGF1R (0.46) MAPK1MAPK8IKBKBCDK1CDK4
SCHEMBL24220845 0.81 MAPK1 (0.68) MAPK1CDK1CDK4CCND1CDK2
SCHEMBL12412586 0.81 MAPK8 (0.43) MAPK1MAPK8CYP1A2CYP3A4MEN1
SCHEMBL3772411 0.81 MAPK8 (0.43) MAPK1MAPK8CYP1A2CYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025245178-A1 PAK4, CSTF2, OR CSTF2T PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS INNOVO THERAPEUTICS, INC. (US) 2025-11-27 — — WO claimed
WO-2025245178-A1 PAK4, CSTF2, OR CSTF2T PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS INNOVO THERAPEUTICS, INC. (US) 2025-11-27 — — WO disclosed
Send feedback